Medpace Holdings ROA 2014-2025 | MEDP
Current and historical return on assets (ROA) values for Medpace Holdings (MEDP) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Medpace Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2025-03-31 | $0.42B | $1.90B | 20.79% |
| 2024-12-31 | $0.40B | $2.10B | 20.45% |
| 2024-09-30 | $0.37B | $2.08B | 19.58% |
| 2024-06-30 | $0.34B | $1.92B | 19.83% |
| 2024-03-31 | $0.31B | $1.80B | 19.73% |
| 2023-12-31 | $0.28B | $1.66B | 19.03% |
| 2023-09-30 | $0.27B | $1.49B | 19.43% |
| 2023-06-30 | $0.27B | $1.41B | 19.62% |
| 2023-03-31 | $0.26B | $1.40B | 19.07% |
| 2022-12-31 | $0.25B | $1.35B | 18.36% |
| 2022-09-30 | $0.23B | $1.33B | 16.01% |
| 2022-06-30 | $0.21B | $1.32B | 14.18% |
| 2022-03-31 | $0.20B | $1.34B | 13.22% |
| 2021-12-31 | $0.18B | $1.66B | 11.82% |
| 2021-09-30 | $0.18B | $1.58B | 12.36% |
| 2021-06-30 | $0.17B | $1.47B | 12.41% |
| 2021-03-31 | $0.16B | $1.45B | 11.79% |
| 2020-12-31 | $0.14B | $1.39B | 11.41% |
| 2020-09-30 | $0.12B | $1.30B | 10.34% |
| 2020-06-30 | $0.11B | $1.22B | 9.36% |
| 2020-03-31 | $0.11B | $1.14B | 10.07% |
| 2019-12-31 | $0.10B | $1.14B | 9.44% |
| 2019-09-30 | $0.09B | $1.07B | 9.06% |
| 2019-06-30 | $0.09B | $1.02B | 8.83% |
| 2019-03-31 | $0.08B | $1.01B | 7.91% |
| 2018-12-31 | $0.07B | $0.97B | 7.57% |
| 2018-09-30 | $0.06B | $0.95B | 6.45% |
| 2018-06-30 | $0.05B | $0.97B | 5.52% |
| 2018-03-31 | $0.05B | $0.97B | 4.80% |
| 2017-12-31 | $0.04B | $0.95B | 4.07% |
| 2017-09-30 | $0.03B | $0.95B | 2.90% |
| 2017-06-30 | $0.02B | $0.96B | 2.37% |
| 2017-03-31 | $0.02B | $0.97B | 2.46% |
| 2016-12-31 | $0.01B | $0.98B | 2.66% |
| 2016-06-30 | $0.01B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.582B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $135.390B | 25.39 |
| Elevance Health (ELV) | United States | $84.947B | 10.96 |
| CVS Health (CVS) | United States | $77.596B | 9.64 |
| Cencora (COR) | United States | $56.866B | 19.78 |
| DiDi Global (DIDIY) | China | $22.921B | 34.79 |
| Natera (NTRA) | United States | $21.460B | 0.00 |
| BioMerieux (BMXMF) | France | $15.355B | 0.00 |
| Solventum (SOLV) | United States | $12.549B | 13.28 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.465B | 0.00 |
| CochLear (CHEOY) | Australia | $11.562B | 0.00 |
| Revvity (RVTY) | United States | $10.871B | 18.71 |
| ICON (ICLR) | Ireland | $10.610B | 9.86 |
| Viatris (VTRS) | United States | $10.094B | 3.47 |
| Doximity (DOCS) | United States | $9.727B | 45.30 |
| Avantor (AVTR) | United States | $8.961B | 13.02 |
| HealthEquity (HQY) | United States | $8.748B | 43.04 |
| Sonic Healthcare (SKHHY) | Australia | $8.220B | 0.00 |
| Charles River Laboratories (CRL) | United States | $6.810B | 13.35 |
| Amplifon S.p.A (AMFPF) | Italy | $4.966B | 27.18 |
| Bausch + Lomb (BLCO) | Canada | $4.171B | 24.58 |
| BrightSpring Health Services (BTSG) | United States | $4.074B | 37.71 |
| Sotera Health (SHC) | United States | $3.528B | 20.05 |
| Surgery Partners (SGRY) | United States | $2.954B | 38.42 |
| Alignment Healthcare (ALHC) | United States | $2.920B | 0.00 |
| Concentras Parent (CON) | United States | $2.761B | 15.96 |
| Organon (OGN) | United States | $2.376B | 2.52 |
| Ardent Health Partners (ARDT) | United States | $2.127B | 9.07 |
| GeneDx Holdings (WGS) | United States | $1.997B | 76.91 |
| Premier (PINC) | United States | $1.896B | 14.39 |
| Progyny (PGNY) | United States | $1.765B | 38.85 |
| PACS (PACS) | United States | $1.558B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.368B | 27.36 |
| Teladoc Health (TDOC) | United States | $1.242B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.190B | 9.05 |
| Establishment Labs Holdings (ESTA) | $1.067B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.998B | 0.00 |
| CareDx (CDNA) | United States | $0.982B | 15.33 |
| Agilon Health (AGL) | United States | $0.923B | 0.00 |
| Nutex Health (NUTX) | United States | $0.911B | 13.77 |
| AMN Healthcare Services Inc (AMN) | United States | $0.822B | 7.70 |
| QDM (QDMI) | Hong Kong, SAR China | $0.743B | 0.00 |
| Embecta (EMBC) | United States | $0.658B | 4.43 |
| InnovAge Holding (INNV) | United States | $0.545B | 0.00 |
| Enhabit (EHAB) | United States | $0.529B | 43.54 |
| LifeMD (LFMD) | United States | $0.524B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.484B | 10.90 |
| SBC Medicals (SBC) | United States | $0.477B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.471B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.400B | 0.00 |
| Oncology Institute (TOI) | United States | $0.269B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.220B | 0.00 |
| Beauty Health (SKIN) | United States | $0.213B | 0.00 |
| KindlyMD (NAKA) | United States | $0.151B | 0.00 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| DocGo (DCGO) | United States | $0.142B | 23.17 |
| OncoCyte (OCX) | United States | $0.093B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.063B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.063B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Biodesix (BDSX) | United States | $0.051B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.020B | 0.00 |
| ModivCare (MODV) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.010B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |